Advent Technologies Announces $2 Million Registered Direct Offering of Common Stock
BOSTON–(BUSINESS WIRE)–Advent Technologies Holdings, Inc. (NASDAQ: ADN) (“Advent” or the “Company”), an innovation-driven leader... Read more.
AEye Announces Reverse Stock Split to Ensure Nasdaq Minimum Bid Price Compliance
DUBLIN, Calif.–(BUSINESS WIRE)–AEye, Inc. (“AEye” or the “Company”) (Nasdaq: LIDR), a global leader in adaptive, high performance lidar solutions,... Read more.
Safe & Green Holdings Corp. Announces That David Cross, VP of Sales and Business Development, Has Been Selected to Serve on the Modular Building Institute’s Government Affairs Committee
MIAMI–(BUSINESS WIRE)–Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a leading developer, designer,... Read more.
Madryn Asset Management Highlights Newly-Disclosed Conflicts of Interest Related to Proposed SomaLogic Merger with Standard BioTools
Late-Stage Updates to Merger Proxy Spotlight Troubling Connections and Ongoing Business Relationships Among Members of SomaLogic Transaction Committee and Eli Casdin... Read more.
THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Theseus Pharmaceuticals, Inc. (NASDAQ: THRX)... Read more.
EGFR Tests Market Forecasts to 2033: Comprehensive Analysis of Size, Share, Regulatory Landscape and Global Trends – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033” report has been added... Read more.
KRTX STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Karuna Therapeutics, Inc. Is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Karuna Therapeutics, Inc. (NASDAQ: KRTX)... Read more.
HB Capital and Social Capital Partners Establish Strategic Partnership to Advance Employee Ownership Initiatives
CAMP HILL, Pa.–(BUSINESS WIRE)–HB Capital is pleased to announce a strategic partnership with Social Capital Partners. This collaboration is geared towards... Read more.
Patritumab Deruxtecan Granted Priority Review in the U.S. for Certain Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Submission based on HERTHENA-Lung01 results showing patritumab deruxtecan demonstrated clinically meaningful and durable responses in patients with advanced EGFR-mutated... Read more.
Sarepta Therapeutics Submits Efficacy Supplement to Expand the ELEVIDYS Label to include Duchenne Muscular Dystrophy Patients without Restriction to Age or Ambulatory Status
Application includes request for Priority Review from the US FDA Sarepta has also submitted the EMBARK postmarketing requirement to the FDA seeking conversion of... Read more.